A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT03747653 · clinicaltrials.gov ↗

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: ADVATE
DRUG: FRSW107

Sponsor

Kaifeng Pharmaceutical (Group) Co., Ltd.

Collaborators

[object Object]